Alexandra Bluhm
Leipzig, SN 04103, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Aberrant FICD-mediated AMPylation drives α-Synuclein pathology and overall protein dyshomeostasis in dopaminergic neurons in Parkinson's disease.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Monomers, Dimers, and Oligomers of Pyroglutamate-Modified α-Synuclein Fragments Exhibit Distinct Biophysical Characteristics.
Journal: ACS chemical neuroscience
Published: April 30, 2025
Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances.
Journal: Behavioural brain research
Published: May 31, 2023
Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
Journal: Behavioural brain research
Published: February 23, 2022
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
Journal: Acta neuropathologica
Published: June 11, 2021
Proteolytic α-Synuclein Cleavage in Health and Disease.
Journal: International journal of molecular sciences
Published: March 30, 2021
Structural Analysis of RNA by Small-Angle X-ray Scattering.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 02, 2020
Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation.
Journal: Molecules (Basel, Switzerland)
Published: March 20, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026